After years of shortages, the Food and Drug Administration (FDA) has now listed Novo Nordisk’s blockbuster diabetes and ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

Novo Nordisk reported one counterfeit pen contained the diabetes medicine insulin ... of Pharmacy has sent up a Safe Site Search Tool which allows users to verify if a website selling medications has ...

You need the best health care providers to ensure a proper hormone balance. Here are the top endocrinologists on.

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Here’s why, what to know about the current lengthy list of unknowns and ... s Feinberg School of Medicine, and chief ...

Only 13 states currently allow Medicaid to cover GLP-1 agonist drugs for obesity treatment, highlighting a significant gap in ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Topline results from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025; Phase 1 results published in The ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Toni:I received my new 2025 Part D premium with the plan increase going up by 250%, from $25 a month to over $60. I was informed that my diabetic insulin ...